BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30231230)

  • 1. Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma.
    Calderaro J; Letouzé E; Bayard Q; Boulai A; Renault V; Deleuze JF; Bestard O; Franco D; Zafrani ES; Nault JC; Moutschen M; Zucman-Rossi J
    N Engl J Med; 2018 Sep; 379(12):1178-1180. PubMed ID: 30231230
    [No Abstract]   [Full Text] [Related]  

  • 2. A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor.
    Sasaki M; Yoneda N; Kitamura S; Sato Y; Nakanuma Y
    Mod Pathol; 2012 Dec; 25(12):1584-93. PubMed ID: 22766792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic AA amyloidosis induced by liver cell adenoma.
    Fievet P; Sevestre H; Boudjelal M; Noel LH; Kemeny F; Franco D; Delamarre J; Capron JP
    Gut; 1990 Mar; 31(3):361-3. PubMed ID: 2157638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic AA amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a 13-year follow up.
    Cosme A; Horcajada JP; Vidaur F; Ojeda E; Torrado J; Arenas JI
    Liver; 1995 Jun; 15(3):164-7. PubMed ID: 7674844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of renal amyloidosis associated with hepatic adenoma: the pathogenetic role of tumor necrosis factor-alpha.
    Shibasaki T; Matsumoto H; Watabe K; Joh K; Nakano H; Matsuda H; Gomi H; Ohno I; Ishimoto F; Sakai O
    Nephron; 1997; 75(3):350-3. PubMed ID: 9069459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of nephrotic syndrome related to AA amyloidosis after hepatic adenomectomy.
    Melin JP; Lecrique T; Wynckel A; Wong T; Noël LH; Belghiti J; Chanard J
    Nephron; 1993; 64(1):157-8. PubMed ID: 8502327
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report.
    Thysell H; Ingvar C; Gustafson T; Holmin T
    J Hepatol; 1986; 2(3):450-7. PubMed ID: 3722793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: a case report.
    Brunt EM; Wolverson MK; Di Bisceglie AM
    Semin Liver Dis; 2005; 25(2):230-6. PubMed ID: 15918151
    [No Abstract]   [Full Text] [Related]  

  • 10. Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report.
    De Vito C; Papathomas G T; Pedica F; Kane P; Amir A; Heaton N; Quaglia A
    Ann Hepatol; 2019; 18(1):263-268. PubMed ID: 31113603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Standing Unresolved Primary Biliary Cholangitis Leading to Systemic Amyloid A Amyloidosis With Predominant Liver Involvement: A Death Case.
    Zhang Y; Luo J; Wang C; Liu J; Zhao Q; Chang Y
    Am J Gastroenterol; 2019 Sep; 114(9):1559-1561. PubMed ID: 31365351
    [No Abstract]   [Full Text] [Related]  

  • 12. AA amyloidosis as a complication of primary lymphedema.
    Beloncle F; Sayegh J; Eymerit-Morin C; Duveau A; Augusto JF
    Amyloid; 2014 Mar; 21(1):54-6. PubMed ID: 23964754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocytosis in a child with a hepatic adenoma.
    Marie-Cardine A; Schneider P; Greene V; Metayer J; Bachy B; Vannier JP
    Med Pediatr Oncol; 2001 Jun; 36(6):659-61. PubMed ID: 11344502
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatocellular glycogenosis and hepatic neoplasms.
    Bannasch P
    Toxicol Pathol; 2010 Oct; 38(6):1000-2. PubMed ID: 21037203
    [No Abstract]   [Full Text] [Related]  

  • 15. [A fatal case of pulmonary non-tuberculous mycobacteriosis with reactive AA amyloidosis].
    Shinozuka N; Kasamatsu N; Seto T; Yasui T; Nakamura A; Hashizume I
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):636-42. PubMed ID: 17763694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal gastrointestinal hemorrhage in a paraplegic man with undiagnosed AA (secondary) amyloidosis.
    Baird-Howell MA; Wurzel J
    Amyloid; 2011 Dec; 18(4):245-8. PubMed ID: 22014073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic secondary AA amyloidosis].
    Cadiñanos J; Costa R; Trujillo D; Real de Asúa D
    Med Clin (Barc); 2015 Apr; 144(7):324-30. PubMed ID: 25023854
    [No Abstract]   [Full Text] [Related]  

  • 18. [AL- and AA-amyloidosis (the status of the problem)].
    Kochubeĭ LN; Vinogradova OM; Serov VV; Vasil'eva NA; Tomas NIu
    Klin Med (Mosk); 1988 Aug; 66(8):7-16. PubMed ID: 3057283
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between benign liver tumors and free radicals].
    Váli L; Szijártó A; Hahn O; Fehér J; Kupcsulik P
    Orv Hetil; 2004 Oct; 145(40):2043-50. PubMed ID: 15559531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.